RecruitingNot ApplicableNCT05803564

Thoracoabdominal Aortic Stent System for Endovascular Treatment of Thoracoabdominal Aortic Dissecting Aneurysm.

Clinical Application of a New Technique of Thoracoabdominal Aortic Stent System for Endovascular Treatment of Thoracoabdominal Aortic Dissecting Aneurysm.

Sponsor

Lifetech Scientific (Shenzhen) Co., Ltd.

Enrollment

46 participants

Start Date

Oct 1, 2021

Study Type

INTERVENTIONAL

Conditions

Thoracoabdominal; Aortic, Aneurysm, Dissecting

Summary

A First in man study to evaluate the safety and efficacy of thoracoabdominal aortic stent system for endovascular treatment of thoracoabdominal aortic dissecting aneurysm.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Thoracoabdominal aortic stent system for people with thoracoabdominal; aortic, aneurysm, dissecting. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEThoracoabdominal aortic stent system

Patients who meet all the inclusion criteria and don't meet the exclusion criteria will be implanted with thoracoabdominal aortic stent system.

Locations(1)

Chinese PLA General Hospita

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05803564

Related Trials

Frailty and Physician Modified Fenestrated Endograft for Thoracoabdominal Aortic Pathologies

NCT045242471 location